Daniela Cipolletta

Company: Seismic Therapeutic

Job title: Senior Director, Immunology

Seminars:

The Poly-Pharmacology of S-4321, a Dual Cell -Bi- Directional PD-1 Agonist for the Treatment of Autoimmune & Inflammatory Diseases 1:30 pm

Discussing the tole of inhibitory receptor in the maintenance of immune tolerance Highlight ongoing research initiatives on dual cell bidirectional PD-1 agonist Explore the intersection of Treg biology and PD-1 agonismRead more

day: Day 2 Treg Modulators Track PM

Panel Discussion: Shaping the Future of Treg Modulators to Produce Cutting-Edge Therapies 2:00 pm

Exploring novel Treg modulators beyond IL-2 (including IL-35 and TNFR-2 agonists) to uncover new therapeutic capabilities Investigating emerging small molecules and biologic modulators to supercharge therapeutic development Discovering antibody-specific Treg modulationRead more

day: Day 1 Treg Modulatorstrack